CONMED Corporation

Healthcare · Medical Devices

45.40$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

CONMED Corporation (CNMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 343 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CNMD
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	185	204	187	197	190	223	202	213	202	242	218	238	234	265	214	158	238	253	233	255	249	274	242	277	275	251	295	318	305	327	312	332	317	346	319	343	339	373	317	343	1,373
Cost of Revenue	84	97	87	93	88	99	93	97	92	110	97	107	103	123	95	86	104	117	104	114	107	118	106	125	123	119	140	147	137	145	140	148	138	148	152	163	181	160	134	146	620
Gross Profit	101	107	100	105	103	124	110	116	111	133	121	131	130	142	119	72	134	136	128	141	142	156	136	152	152	132	155	171	168	182	172	184	179	198	168	181	158	213	183	197	752
Research & Development	8.4	7.6	7.6	8.0	8.3	8.4	7.7	10.0	14	10	11	12	11	12	10	8.7	9.9	12	10	11	11	11	11	11	13	12	13	14	12	14	14	14	14	13	13	14	14	15	16	16	61
Selling, General & Administrative	79	87	95	84	81	92	85	90	85	96	99	101	98	102	96	84	94	96	98	104	105	107	103	116	115	121	130	130	125	118	123	123	100	133	149	121	122	167	142	146	576
Total Operating Expenses	87	94	102	92	89	101	92	100	99	107	110	113	109	114	106	93	104	111	108	116	116	119	114	127	127	133	143	143	138	132	137	137	113	146	156	139	139	146	158	161	604
Operating Income	14	13	-2.5	13	13	23	17	17	12	26	12	19	21	28	13	-21	29	25	20	26	27	37	22	24	24	-1.1	13	27	30	50	35	47	66	52	11	42	19	67	25	36	148
Interest Expense	3.9	3.9	4.1	4.4	4.8	4.9	4.8	5.1	5.2	5.5	9.4	12	11	10	9.6	11	12	11	10	9.4	8.1	7.6	5.0	5.9	8.5	9.4	10	10.0	10	9.5	9.6	9.6	9.3	8.9	8.3	7.8	7.6	7.4	7.1	7.9	30
Pre-Tax Income	10.0	8.7	-6.6	8.4	8.7	18	12	12	6.3	20	-2.0	6.5	9.4	17	3.5	-33	17	13	9.7	16	17	30	17	-93	16	-11	2.4	17	20	41	25	38	56	44	7.7	30	4.3	29	18	31	83
Income Tax Expense	2.6	2.0	-2.1	2.2	1.5	-28	1.8	2.9	0.5	4.6	-3.0	0.8	2.5	2.3	-2.4	-5.3	11	-11	-0.1	3.0	2.5	5.2	2.5	75	-30	-37	0.6	3.7	4.4	7.6	5.7	7.5	7.5	9.9	1.6	8.5	1.4	13	4.5	8.3	27
Net Income	7.3	6.7	-4.5	6.1	7.2	47	11	8.7	5.8	16	1.0	5.7	7.0	15	5.9	-27	6.9	24	9.9	13	15	24	15	-168	46	27	1.8	14	16	33	20	30	49	34	6.0	21	2.9	17	14	23	56
EBITDA	28	27	11	27	28	39	33	32	27	41	25	37	40	44	32	-3.1	47	43	38	38	43	55	39	-75	42	17	31	40	43	68	53	65	84	71	29	51	25	55	38	61	180

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings